Purpose To investigate the genetic and phenotypic spectrum of IMPG2 -associated retinopathy in a Korean population. Methods This retrospective multicenter study included patients with genetically confirmed IMPG2 -associated retinopathy from four institutions in Korea. Comprehensive clinical features, including visual acuity, fundus appearance, and OCT findings were analyzed. Genetic testing was performed using targeted next-generation sequencing panels or whole-exome sequencing. The identified variants were classified according to ACMG guidelines to determine their pathogenicity. Results Fourteen patients (11 males, 3 females; mean age, 41.4 ± 22.6 years) were included. Thirteen exhibited bilateral involvement. Clinical diagnoses comprised adult-onset vitelliform macular dystrophy ( n = 7), retinitis pigmentosa ( n = 6), and atypical macular dystrophy characterized by subtle, multifocal photoreceptor alterations ( n = 1). Splicing variants at the exon 7–8 junction (c.828+1G>A, c.829-2_829-1delAG) and a splice acceptor variant at exon 9 (c.909–2A>T) were identified in 12 of 14 patients (85.7%), with c.828+1G>A being the most frequent (8/14, 57.1%). 84.2% of the identified variants and 92.9% of the patients harbored loss-of-function mutations, including splicing, frameshift, and nonsense variants. Conclusion Loss-of-function of IMPG2 , including haploinsufficiency, appears to play a major role in IMPG2 -associated retinopathy. The predominance and clustering of splice-site variants around the exon 7–8 junction may reflect a founder effect and regional sequence susceptibility.
No takes yet. Share an insight, caveat, or question.
Song et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: